Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Specialty chemicals and life-science ingredients company demerged from Jubilant Life Sciences in 2021. Operates three segments: specialty chemicals (pyridine, picolines and derivatives used in agrochemicals and pharma), nutrition and health solutions (vitamin B3/niacinamide, choline chloride, animal nutrition premixes), and chemical intermediates (acetic anhydride, ethyl acetate and other acetyls). Also building a CDMO business in fine chemicals.
Among the world's largest producers of pyridine-beta and select pyridine derivatives, and a leading global maker of vitamin B3.
Jubilant Ingrevia Ltd. is a constituent of NIFTY 500, NIFTY SMALLCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Jubilant Ingrevia Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
Per-share figures are not restated. Shares outstanding changed from 15.80 crore to 0.01 crore in FY25, consistent with a bonus issue or stock split. Each year's EPS and book value below are as that year was filed, on that year's share count — so the per-share line falls across FY25 even where profit did not. Compare the absolute figures (EBITDA, free cash flow, total debt) and the margins across that boundary, not the per-share ones.
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 17.59 | 15.89 | 11.56 |
| Book value / share (₹) | 3,12,622.00 | 2,92,708.00 | 173.26 |
| Return on equity | 8.9% | 8.6% | 6.7% |
| Return on capital employed | 10.1% | 10.0% | 8.3% |
| Operating margin | 8.9% | 8.7% | 6.9% |
| Net margin | 6.3% | 6.0% | 4.4% |
| EBITDA | ₹567 Cr | ₹519 Cr | ₹421 Cr |
| Free cash flow | ₹225 Cr | ₹142 Cr | ₹-138 Cr |
| Total debt | ₹792 Cr | ₹764 Cr | ₹733 Cr |
| Debt to equity | 0.25 | 0.26 | 0.27 |
| Interest coverage | 8.0 | 6.5 | 5.4 |
| Current ratio | 1.29 | 1.32 | 1.38 |
| Shares outstanding | 1,00,000 | 1,00,000 | 15,80,00,000 |
Open the full income statement, balance sheet and cash flow for JUBLINGREA →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.